Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector

Journal of Nippon Medical School

Volumn 76, Issue 3, 2009, Pages 134-147

  Uchida, Naoya ^a   Hanawa, Hideki ^a   Dan, Kazuo ^a   Inokuchi, Koiti ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

BCR ABL; Integration site; Lentiviral vector; Leukemogenesis; Mouse leukemia model

Indexed keywords

BCR ABL PROTEIN; COMPLEMENTARY DNA; HEMOGLOBIN; LENTIVIRUS VECTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLAST CELL; BLOOD SAMPLING; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; GENE TRANSFER; HEMOGLOBIN BLOOD LEVEL; IN VIVO STUDY; LEUKEMOGENESIS; LEUKOCYTE COUNT; MOUSE; MYELOID LEUKEMIA; NONHUMAN; THROMBOCYTE COUNT;

ANIMALS; BLOTTING, SOUTHERN; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC VECTORS; LENTIVIRUS; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TIME FACTORS; TRANSDUCTION, GENETIC; WHOLE-BODY IRRADIATION;

EID: 67649834098     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.76.134     Document Type: Article

References (29)

1. Nowell PC: The minute chromosome (Phl) in chronic granulocytic leukemia. Blut 1962; 8: 65-66.
2. Rowley JD: Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-293.
3. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375-2384.
4. Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F: BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene 2002; 21: 8652-8667.
5. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985; 315: 550-554.
6. Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, HM Kantarjian: The biology of chronic myeloid leukemia. N Engl J Med 1999; 341: 164-172.
7. Mills KI, MacKenzie ED, Birnie GD: The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients. Blood 1988; 72: 1237-1241.
8. Fioretos T, Nilsson PG, Aman P, et al.: Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia. Leukemia 1993; 7: 1225-1231.
9. Shepherd P, Suffolk R, Halsey J, Allan N: Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. Br J Haematol 1995; 89: 546-554.
10. Inokuchi K, Inoue T, Tojo A, et al.: A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 1991; 78: 3125-3127.
11. Heisterkamp N, Jenster G, Kioussis D, Pattengale PK, Groffen J: Human bcr-abl gene has a lethal effect on embryogenesis. Transgenic Res 1991; 1: 45-53.
12. Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA: The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399-1412.
13. Scherr M, Eder M: Gene transfer into hematopoietic stem cells using lentiviral vectors. Curr Gene Ther 2002; 2: 45-55.
14. Hanawa H, Kelly PF, Nathwani AC, et al.: Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 2002; 5: 242-251.
15. Hanawa H, Persons DA, Nienhuis AW: Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors. J Virol 2005; 79: 8410-8421.
16. Hanawa H, Hargrove PW, Kepes S, Srivastava DK, Nienhuis AW, Persons DA: Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia. Blood 2004; 104: 2281-2290.
17. Hanawa H, Hematti P, Keyvanfar K, et al.: Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 2004; 103: 4062-4069.
18. Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K: Titering lentiviral vectors: comparison of DNA RNA and marker expression methods. Gene Ther 2002; 9: 1155-1162.
19. Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, Pendergast AM: Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. Blood 2000; 95: 2913-2921.
20. Hematti P, Hong BK, Ferguson C, et al.: Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol 2004; 2: e423.
21. Schmidt M, Zickler P, Hoffmann G, et al.: Polyclonal long-term repopulating stem cell clones in a primate model. Blood 2002; 100: 2737-2743.
22. Mitchell RS, Beitzel BF, Schroder AR, et al.: Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004; 2: E234.
23. Wu X, Li Y, Crise B, Burgess SM: Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749-1751.
24. Kavalerchik E, Goff D, Jamieson CH: Chronic myeloid leukemia stem cells. J Clin Oncol 2008; 26: 2911-2915.
25. Castor A, Nilsson L, Astrand-Grundstrom I, et al.: Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 2005; 11: 630-637.
26. Kumar M, Keller B, Makalou N, Sutton RE: Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 2001; 12: 1893-1905.
27. Honda H, Fujii T, Takatoku M, et al.: Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 1995; 85: 2853-2861.
28. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N: BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 1995; 86: 4603-4611.
29. Honda H, Oda H, Suzuki T, et al.: Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. Blood 1998; 91: 2067-2075.